Companies › NVNO
ENVVENO MEDICAL CORPORATION (NVNO)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001661053 · EDGAR filings · Updated 2026-07-14
ENVVENO MEDICAL CORPORATION (NVNO) has reported institutional ownership of 15.3%, with 17 institutional managers holding positions valued at $1.02M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-14 — Current report (8-K) filed
- 2026-06-12 — Insider transaction reported (Form 4)
- 2026-06-11 — Notice of proposed sale filed (Form 144)
- 2026-05-15 — SCHEDULE 13G/A filed
- 2026-05-15 — SCHEDULE 13G/A filed
- 2026-05-06 — Quarterly report (10-Q) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ENVVENO MEDICAL CORPORATION has 17 institutional holders and institutional ownership of 15.3%.
Insider activity
Insiders reported 3 transactions (0 buys, 3 sells) across 3 reporting insiders, with a net reported value of −$7.44K.
Data flags from SEC filings
Related companies
Mannatech Inc (MTEX) · CHARMING MEDICAL LTD (MCTA) · ALLARITY THERAPEUTICS INC (ALLR) · BioNano Genomics Inc (BNGO) · Icecure Medical Ltd (ICCM) · JYONG BIOTECH LTD (MENS)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-14.